Clinical Trial Update: Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma

View source ↗

Summary

A clinical trial update evaluating whether the CD4/CD8 T-cell ratio has prognostic value in patients with Nasopharyngeal carcinoma who have no distant metastase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Jiangxi Provincial Cancer Hospital | Conditions: Histopathological Diagnosis of Nasopharyngeal Carcinoma, Patients with Nasopharyngeal Carcinoma Without Distant Metastases After AJCC/UACC 8th Edition | Status: ACTIVE_NOT_RECRUITING